Patents by Inventor Neil Faulkner

Neil Faulkner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7168989
    Abstract: A module for the assembly of two sets of connections, which have on their respective coupling faces a set of contacts whose contacts are distributed according to different layouts and densities, the module comprising a first set of contacts connected to a first printed circuit board, a second set of contacts connected to a second printed circuit board, wherein a central core arranged between the first and the second printed circuit board is provided with cutouts for the positioning and holding in place of conductors in order to provide electrical continuity between the contacts of the first and second set of contacts.
    Type: Grant
    Filed: January 17, 2006
    Date of Patent: January 30, 2007
    Assignee: Souriau
    Inventor: Neil Faulkner
  • Publication number: 20060172601
    Abstract: A module for the assembly of two sets of connections, which have on their respective coupling faces a set of contacts whose contacts are distributed according to different layouts and densities, the module comprising a first set of contacts connected to a first printed circuit board, a second set of contacts connected to a second printed circuit board, wherein a central core arranged between the first and the second printed circuit board is provided with cutouts for the positioning and holding in place of conductors in order to provide electrical continuity between the contacts of the first and second set of contacts.
    Type: Application
    Filed: January 17, 2006
    Publication date: August 3, 2006
    Inventor: Neil Faulkner
  • Publication number: 20020137704
    Abstract: Methods are provided for inhibiting or suppressing viral replication in an infected host cell. More specifically, methods are provided for inhibiting or suppressing viral replication in an infected host cell by administering compounds that inhibit cellular protein phosphatase 2A. Such methods are advantageous for treating viral infections such human immunodefeciency virus infections.
    Type: Application
    Filed: June 11, 2001
    Publication date: September 26, 2002
    Inventors: David M. Markovitz, Neil Faulkner, Brian Lane